In one of outsourcing’s newest frontiers, the drug-safety monitoring business is booming in India as regulators require closer tracking of side effects.
from WSJ.com: US Business http://ift.tt/16hhccd
via IFTTT
from WSJ.com: US Business http://ift.tt/16hhccd
via IFTTT
No comments:
Post a Comment